Conclusions
diabetes, CMT
FOLLOWING CATARACT SURGERY, DIABETES
In conclusion, the current randomized clinical trial suggests that prophylactic topical ketorolac 0.5% three times a day might not decrease CMT and improve visual acuity compared to placebo following cataract surgery in patients with diabetes. However, further studies with larger sample sizes are recommended.